16 research outputs found
The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study
<p>Abstract</p> <p>Background</p> <p>Lipocalin-2 is a novel adipokine that appears to play a role in the development of insulin resistance. Serum lipocalin-2 levels are elevated in obese patients. Obesity and insulin resistance are cardinal characteristics of the polycystic ovary syndrome (PCOS). However, there are limited data on serum lipocalin-2 levels in patients with PCOS. The aim of the present study was to assess serum lipocalin-2 levels in PCOS.</p> <p>Methods</p> <p>We studied 200 patients with PCOS and 50 healthy female volunteers.</p> <p>Results</p> <p>Serum lipocalin-2 levels were slightly higher in women with PCOS compared with controls (65.4 +/- 34.3 vs. 60.3 +/- 26.0 ng/ml, respectively) but this difference did not reach statistical significance. In contrast, lipocalin-2 levels were higher in overweight/obese women with PCOS than in normal weight women with the syndrome (76.2 +/- 37.3 vs. 54.5 +/- 27.2 ng/ml, respectively; p < 0.001). Serum lipocalin-2 levels were also higher in overweight/obese controls compared with normal weight controls (70.1 +/- 24.9 vs. 50.5 +/- 23.7 ng/ml, respectively; p = 0.004). In the total study population (patients with PCOS and controls), lipocalin-2 levels were independently correlated with the body mass index (p < 0.001). In women with PCOS, lipocalin-2 levels were independently correlated with the waist (p < 0.001).</p> <p>Conclusions</p> <p>Obesity is associated with elevated serum lipocalin-2 levels. In contrast, PCOS does not appear to affect lipocalin-2 levels.</p
Transcriptional regulation of endothelin-1 expression by advanced glycation end-products in human aortic endothelium is mediated via NF-kappaΒ and AP-1
Advanced Glycation End-products (AGEs) are produced by the non-enzymatic glycation of proteins, lipids and nucleic acids, resulting in an overload of highly reactive molecules of endogenous or exogenous (dietary) origin.
Increased AGE levels in circulation and concomitant elevated tissue deposition have been associated with diabetic complications, atheromatosis, ageing and more recently with polycystic ovary syndrome pathogenesis.
Interaction of AGEs with their receptor RAGE (Receptor for AGEs) activates intracellular signaling pathways which induce targeted gene expression in endothelium including upregulation of cell adhesion molecules and endothelin-1 (ET-1), implicated in vascular injury and endothelial dysfunction.
The purpose of this study is to explore the molecular mechanism of AGE-induced regulation of ET-1 gene/protein expression in human endothelial cells and investigate its functional relevance in normal rat vascular endothelium
The importance of myo-inositol and D-chiro-inositol to support fertility and reproduction
This review details the physiologic roles of two insulin sensitizers, myo-inositol (MI) and D-chiro-inositol (DCI). In the human ovary, MI is a second messenger of follicle stimulating hormone (FSH) and DCI is an aromatase inhibitor. These activities allow a treatment for polycystic ovary syndrome (PCOS) to be defined based on the combined administration of MI and DCI, where the best MI:DCI ratio is 40:1. In addition, MI plays a pivotal role in the physiology of reproduction, and has beneficial effects on the development of oocytes, spermatozoa, and embryos. By contrast, DCI has little effect on spermatozoa, but high concentrations in the ovary can negatively affect the quality of oocytes and the blastocyst. Overall, the evidence in the literature supports the beneficial effects of MI in both female and male reproduction, warranting clinical use of MI in assisted reproductive treatment (ART).Cette revue détaille les rôles physiologiques de deux sensibilisateurs à l'insuline, le myo-inositol (MI) et le D-chiro-inositol (DCI). Dans l'ovaire humain, le MI est un second messager de l'hormone folliculostimulante (FSH) et le DCI est un inhibiteur de l'aromatase. Ces activités permettent de définir un traitement du syndrome des ovaires polykystiques (SOPK) basé sur l'administration combinée de MI et de DCI, où le meilleur rapport MI:DCI est de 40:1. En outre, le MI joue un rôle essentiel dans la physiologie de la reproduction et a des effets bénéfiques sur le développement des ovocytes, des spermatozoïdes et des embryons. En revanche, le DCI a peu d'effet sur les spermatozoïdes, mais des concentrations élevées dans l'ovaire peuvent avoir un effet négatif sur la qualité des ovocytes et du blastocyste. Dans l'ensemble, les données de la littérature confirment les effets bénéfiques du MI dans la reproduction féminine et masculine, ce qui justifie l'utilisation clinique du MI dans l'assistance médicale à la procréation
Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease
Endocrine disrupting chemicals (EDCs), a heterogeneous group of exogenous chemicals that can interfere with any aspect of endogenous hormones, represent an emerging global threat for human metabolism. There is now considerable evidence that the observed upsurge of metabolic disease cannot be fully attributed to increased caloric intake, physical inactivity, sleep deficit, and ageing. Among environmental factors implicated in the global deterioration of metabolic health, EDCs have drawn the biggest attention of scientific community, and not unjustifiably. EDCs unleash a coordinated attack toward multiple components of human metabolism, including crucial, metabolically-active organs such as hypothalamus, adipose tissue, pancreatic beta cells, skeletal muscle, and liver. Specifically, EDCs' impact during critical developmental windows can promote the disruption of individual or multiple systems involved in metabolism, via inducing epigenetic changes that can permanently alter the epigenome in the germline, enabling changes to be transmitted to the subsequent generations. The clear effect of this multifaceted attack is the manifestation of metabolic disease, clinically expressed as obesity, metabolic syndrome, diabetes mellitus, and non-alcoholic fatty liver disease. Although limitations of EDCs research do exist, there is no doubt that EDCs constitute a crucial parameter of the global deterioration of metabolic health we currently encounter
MECHANISMS IN ENDOCRINOLOGY Nutrition as a mediator of oxidative stress in metabolic and reproductive disorders in women
Nutrition can generate oxidative stress and trigger a cascade of
molecular events that can disrupt oxidative and hormonal balance.
Nutrient ingestion promotes a major inflammatory and oxidative response
at the cellular level in the postprandial state, altering the metabolic
state of tissues. A domino of unfavorable metabolic changes is
orchestrated in the main metabolic organs, including adipose tissue,
skeletal muscle, liver and pancreas, where subclinical inflammation,
endothelial dysfunction, mitochondrial deregulation and impaired insulin
response and secretion take place. Simultaneously, in reproductive
tissues, nutrition-induced oxidative stress can potentially violate
delicate oxidative balance that is mandatory to secure normal
reproductive function. Taken all the above into account, nutrition and
its accompanying postprandial oxidative stress, in the unique context of
female hormonal background, can potentially compromise normal metabolic
and reproductive functions in women and may act as an active mediator of
various metabolic and reproductive disorders
Postprandial dysmetabolism: Too early or too late?
Postprandial dysmetabolism is a postprandial state characterized by
abnormal metabolism of glucose and lipids and, more specifically, of
elevated levels of glucose and triglyceride (TG) containing
lipoproteins. Since there is evidence that postprandial dysmetabolism is
associated with increased cardiovascular mortality and morbidity, due to
macro-and microvascular complications, as well as with conditions such
as polycystic ovary syndrome (PCOS) and nonalcoholic fatty liver disease
(NAFLD), it is recommended that clinicians be alert for early detection
and management of this condition. Management consists of a holistic
approach including dietary modification, exercise and use of
hypoglycemic and hypolipidemic medication aiming to decrease the
postprandial values of circulating glucose and triglycerides. This
review aims to explain glucose and lipid homeostasis and the impact of
postprandial dysmetabolism on the cardiovascular system as well as to
offer suggestions with regard to the therapeutic approach for this
entity. However, more trials are required to prevent or reverse early
and not too late the actual tissue damage due to postprandial
dysmetabolism
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.
Polycystic ovary syndrome (PCOS) is a heterogeneous syndrome, with long-term sequelae from birth to senescence. The long-term effects of PCOS are attributed to several metabolic aberrations ensuing the syndrome. In a systematic review of literature regarding the cardiovascular risk factors that accompany PCOS, we found that macrovascular function has been assessed by flow-mediated dilatation (FMD), microvascular function by venous occlusion plethysmography (VOP), and arterial structure by ultrasonographic assessment of intima-media thickness (IMT) usually of the carotid artery. Contradictory results have been reported; however, in most studies, endothelial dysfunction, an early marker of atherosclerosis assessed either by haemodynamic methods such as FMD or by biochemical methods such as endothelin-1 levels, was found to be impaired. VOP is a less-studied method, with few indices altered. IMT was found to be altered in most of the included studies, but the population was more heterogeneous. Inflammatory markers, including C-reactive protein, were also found to be altered in most studies. On the other hand, a number of interventions have been shown beneficial for the markers of cardiovascular risk, in the context of insulin-sensitizers. However, other interventions such as oral contraceptive pills or statins did not consistently show a similar beneficial effect. In summary, the early identification and eventual treatment of cardiovascular clinical and biochemical risk factors may be used in clinical practice to prevent potential 'silent' triggers of cardiovascular disease
Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome
Interference of Advanced Glycation End-products signaling with collagen cross-linking in human endothelium
Maintenance of extracellular matrix (ECM) stability is critical for vascular remodeling associated with cardiovascular diseases. Covalent cross-linking of collagen and elastin initiated by the copper-dependent lysyl oxidase (LOX) is a central event assuring ECM stability and vascular homeostasis. LOX downregulation leads to endothelial dysfunction characteristic of early atherosclerotic stages, whereas its upregulation in vascular cells can induce neointimal thickening in atherosclerosis and restenosis. Advanced Glycation End-products (AGEs), the highly reactive products of non-enzymatic glycation of proteins, lipids and nucleic acids, contribute to endothelial dysfunction, atherosclerosis and vascular injury under both normal and diabetic conditions.
The aim of the present study was to investigate the effect of AGEs in regulation of LOX gene/protein expression in human endothelial cells and to explore the potential functional impact of this interaction in an animal model